119th Congress · Senate bill · Last action Apr 10, 2025
S. 1414In CommitteeHealth
Senate advances expedited pathway for biosimilar drug approvals
Sponsor: Sen. Paul, Rand (R-KY)2 cosponsorsIntroduced Apr 10, 2025
✆
In plain English
A plain-English summary isn’t available for this bill yet.
Where it is in the process
✓
Introduced
Apr 10
✓
Senate committee
Apr 10
3
Senate floor
-
4
House
-
5
Signed
-
What happens next: Sits in committee. Needs a markup or favorable report to advance to the Senate floor.
Community vote
How readers of ThePolitibase feel about this bill. Reader sentiment only — not a scientific poll, and not a measure of public opinion.
- support · - oppose · - total
Sponsor
RS
Cosponsors (2)
MS
MS
1 Democrat, 1 Republican (of 2 shown).
Activity timeline
Apr 10
Apr 10, 2025
Apr 10, 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Apr 10
Apr 10, 2025
Apr 10, 2025
Introduced in Senate
Read the bill text
Official text via Congress.gov. Opens in a new tab.
Full action log
All 2 recorded actions since introduction · Source: Congress.gov
Apr 10
SENATERead twice and referred to the Committee on Health, Education, Labor, and Pensions.
Apr 10
Introduced in Senate
All 2 cosponsors
1 Democrat · 1 Republican
Democrats (1)
Republicans (1)
In the news
Track this bill
Get an alert when it moves to the next stage or gets a vote.